THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Clinical trials for THERAPY-RELATED ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new THERAPY-RELATED ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for THERAPY-RELATED ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope to stop Leukemia's return after transplant
Disease control OngoingThis study is testing whether adding two drugs, venetoclax and azacitidine, after a stem cell transplant can help prevent high-risk leukemia from returning. It is for adults aged 18-75 with certain types of acute leukemia who have already had a transplant. The goal is to see if t…
Matched conditions: THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug combo aims to keep deadly blood cancer at bay
Disease control OngoingThis study is testing whether a two-drug combination (azacitidine and venetoclax) can help keep acute myeloid leukemia (AML) from returning in patients who have achieved remission. The trial will enroll 50 adults with AML who are in remission but are not immediate candidates for …
Matched conditions: THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for Tough-to-Treat leukemia: experimental drug added to standard chemo
Disease control OngoingThis study is testing a new drug called pevonedistat, given alongside standard chemotherapy drugs, for adults newly diagnosed with high-risk acute myeloid leukemia (AML). The main goals are to find the safest and most effective dose of the new combination and to see if it helps m…
Matched conditions: THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New hope for tough leukemia in younger patients
Disease control OngoingThis study is testing how well a chemotherapy drug called CPX-351 works for adults under 60 with secondary acute myeloid leukemia, a type of blood cancer that develops from other blood disorders or previous cancer treatments. The goal is to see if this drug can help patients achi…
Matched conditions: THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC